HC Wainwright reaffirmed their buy rating on shares of Dianthus Therapeutics (NASDAQ:DNTH – Free Report) in a report issued ...

Wedbush reissued their outperform rating on shares of Dianthus Therapeutics (NASDAQ:DNTH – Free Report) in a research note ...

Given this risk, we thought we'd take a look at whether Dianthus Therapeutics (NASDAQ:DNTH) shareholders should be worried about its cash burn. For the purposes of this article, c ...

Full Year 2024 Results Key Financial Results Net loss: US$85.0m (loss widened ...

Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.85. This compares to loss of $0.71 per share a year ago. These ...

Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) ongoing; top-line results on track for 2H’25Phase 3 CAPTIVATE trial of ...

Reports Q4 revenue $1.33M, consensus $859,700. “We remain on track to report top-line data in 2H’25 from our Phase 2 clinical trial of DNTH103 ...

If your garden is looking bare and lifeless, one gardening expert has shared the best flowers to plant this spring.

America Selections organization enlists more than 80 horticulture professionals from around the U.S. and in Canada to serve as plant-trial judges.

NEW YORK and WALTHAM, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody ...

(Bred by Takii Europe B.V.) Dianthus Interspecific Capitán Magnifica (National) This new dianthus thrived through the test gardens’ summer heat. Its two-toned pink flowers, held on long stems, are ...

February is the month when indoor seed-starting takes center stage in the Northern gardening world. It’s when eager gardeners get busy starting their cool-season plants, such as cabbage ...